Document is current
Any future updates will be listed below
-
Authors
De Salvo, Gabriella http://orcid.org/0000-0002-1185-6942
Thulasidharan, Suresh http://orcid.org/0000-0002-4791-5131
Barbara, Ramez
Penwarden, Alison
Aggarwal, Nishant http://orcid.org/0000-0002-1931-390X
Frisina, Rino http://orcid.org/0000-0002-0247-2680
- License Information
-
More Information
Article History
Received: 1 November 2023
Revised: 17 May 2024
Accepted: 3 July 2024
First Online: 12 July 2024
Competing interests
: GDS – is Advisory Board member to Novartis, Bayer, Teva, Allergan and Apellis. She has received Travel grants from Heidelberg Engineering, Novartis, Bayer, Roche, Allergan and also received educational grant from Bayer. She has also done Consultancy work to Boehringer Ingelheim. Dr De Salvo also serves as the section editor to the Eye Journal. RF – is a member of the editorial board to the Eye Journal. The remaining authors decalre no competing interests.
